HealthCare Global Enterprises Limited

NSEI:HCG Stock Report

Market Cap: ₹74.0b

HealthCare Global Enterprises Past Earnings Performance

Past criteria checks 4/6

HealthCare Global Enterprises has been growing earnings at an average annual rate of 57%, while the Healthcare industry saw earnings growing at 22.7% annually. Revenues have been growing at an average rate of 16% per year. HealthCare Global Enterprises's return on equity is 6.8%, and it has net margins of 2.8%.

Key information

57.0%

Earnings growth rate

59.7%

EPS growth rate

Healthcare Industry Growth29.4%
Revenue growth rate16.0%
Return on equity6.8%
Net Margin2.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Pinning Down HealthCare Global Enterprises Limited's (NSE:HCG) P/S Is Difficult Right Now

Dec 22
Pinning Down HealthCare Global Enterprises Limited's (NSE:HCG) P/S Is Difficult Right Now

HealthCare Global Enterprises Limited Just Missed Earnings - But Analysts Have Updated Their Models

Nov 13
HealthCare Global Enterprises Limited Just Missed Earnings - But Analysts Have Updated Their Models

We Take A Look At Why HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation Is Well Earned

Sep 19
We Take A Look At Why HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation Is Well Earned

HealthCare Global Enterprises Limited Just Missed EPS By 79%: Here's What Analysts Think Will Happen Next

Feb 11
HealthCare Global Enterprises Limited Just Missed EPS By 79%: Here's What Analysts Think Will Happen Next

We Think Shareholders Will Probably Be Generous With HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation

Sep 14
We Think Shareholders Will Probably Be Generous With HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation

A Look At The Fair Value Of HealthCare Global Enterprises Limited (NSE:HCG)

Sep 05
A Look At The Fair Value Of HealthCare Global Enterprises Limited (NSE:HCG)

HealthCare Global Enterprises Limited's (NSE:HCG) Business Is Yet to Catch Up With Its Share Price

May 17
HealthCare Global Enterprises Limited's (NSE:HCG) Business Is Yet to Catch Up With Its Share Price

Does HealthCare Global Enterprises (NSE:HCG) Have A Healthy Balance Sheet?

Jun 24
Does HealthCare Global Enterprises (NSE:HCG) Have A Healthy Balance Sheet?

Shareholders Shouldn’t Be Too Comfortable With HealthCare Global Enterprises' (NSE:HCG) Strong Earnings

Jun 03
Shareholders Shouldn’t Be Too Comfortable With HealthCare Global Enterprises' (NSE:HCG) Strong Earnings

Is HealthCare Global Enterprises (NSE:HCG) Using Too Much Debt?

Dec 08
Is HealthCare Global Enterprises (NSE:HCG) Using Too Much Debt?

What Does HealthCare Global Enterprises Limited's (NSE:HCG) Share Price Indicate?

Jun 25
What Does HealthCare Global Enterprises Limited's (NSE:HCG) Share Price Indicate?

Insider Buying: The HealthCare Global Enterprises Limited (NSE:HCG) Executive Chairman Just Bought ₹2.4m Worth Of Shares

Mar 14
Insider Buying: The HealthCare Global Enterprises Limited (NSE:HCG) Executive Chairman Just Bought ₹2.4m Worth Of Shares

The HealthCare Global Enterprises (NSE:HCG) Share Price Is Up 51% And Shareholders Are Holding On

Mar 03
The HealthCare Global Enterprises (NSE:HCG) Share Price Is Up 51% And Shareholders Are Holding On

Revenue & Expenses Breakdown

How HealthCare Global Enterprises makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NSEI:HCG Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2420,4365706240
30 Jun 2419,77052600
31 Mar 2419,1214826240
31 Dec 2318,5923537650
30 Sep 2318,1403717650
30 Jun 2317,47130900
31 Mar 2316,9442937650
31 Dec 2216,1742702740
30 Sep 2215,507-2642740
30 Jun 2214,82769400
31 Mar 2213,9785372740
31 Dec 2113,312-5441900
30 Sep 2112,472-3791900
30 Jun 2111,431-1,63300
31 Mar 2110,134-1,9351900
31 Dec 209,858-1,3492890
30 Sep 209,897-1,2842890
30 Jun 2010,202-1,28400
31 Mar 2010,956-1,0672890
31 Dec 1910,832-7186850
30 Sep 1910,541-5526850
30 Jun 1910,210-39400
31 Mar 199,787-2486850
31 Dec 189,430-1356230
30 Sep 189,004-416230
30 Jun 188,6611246230
31 Mar 188,3072056230
31 Dec 177,9092574400
30 Sep 177,6082784400
30 Jun 177,23721900
31 Mar 177,0012304400
31 Dec 166,7052082980
30 Sep 166,3921332980
30 Jun 166,081672980
31 Mar 165,842-1783200
31 Dec 155,611-33680
30 Sep 155,4949579110
30 Jun 155,32392170
31 Mar 155,19482990
31 Mar 144,513-3562540

Quality Earnings: HCG has high quality earnings.

Growing Profit Margin: HCG's current net profit margins (2.8%) are higher than last year (2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: HCG has become profitable over the past 5 years, growing earnings by 57% per year.

Accelerating Growth: HCG's earnings growth over the past year (53.8%) is below its 5-year average (57% per year).

Earnings vs Industry: HCG earnings growth over the past year (53.8%) exceeded the Healthcare industry 29.6%.


Return on Equity

High ROE: HCG's Return on Equity (6.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 02:34
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

HealthCare Global Enterprises Limited is covered by 20 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Candice PereiraAnand Rathi Shares and Stock Brokers Limited
Kripashankar MauryaChoice Equity Broking Private Limited
Deepika MurarkaChoice Equity Broking Private Limited